Screening for aortic aneurysm. (Clinical Capsules).
The MASS trial involved a population-based sample of 67,800 men aged 65-74 years. Of the nearly 34,000 who were invited to a free ultrasound screening, 1,333 were found to have abdominal aortic aneurysms. Most of these (944) were small and were rescanned at yearly intervals; the 223 medium-sized lesions were rescanned at 3-month intervals. Patients with large aneurysms (166) were referred for surgical repair (Lancer 360:1531-39, 2002).
Over 4 years of follow-up, 65 of the men who had been offered screening died of causes related to aneurysm, compared with 113 of the men who were not offered screening. They estimated that screening cut the risk of dying from abdominal aortic aneurysm from 3.3 per 1,000 to 1.9 per 1,000 men, and that 1 such death would be prevented for every 710 men screened.
|Printer friendly Cite/link Email Feedback|
|Author:||Moon, Mary Ann|
|Publication:||Internal Medicine News|
|Article Type:||Brief Article|
|Date:||Jan 15, 2003|
|Previous Article:||Surgery conditions right ventricle, cuts CHF class. (Thromboendarterectomy).|
|Next Article:||Markers predict CHF progression. (Clinical Capsules).|